The molecular diagnostics equipment provider has completed a $11.3m investment from China-based Autobio Diagnostics that was announced in December.

Diagnostics product manufacturer Autobio Diagnostics has closed €10m ($11.3m) in funding for Finland-headquartered molecular diagnostics technology developer Mobidiag. Founed in 2000, Mobidiag provides technology that is used by clinical laboratories to detect infectious diseases including those that are currently resistance to antibiotics. The company’s platform is designed to screen multiple or single pathogens within a…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.